Cutting co-pays helps. What if you eliminated or really whacked co-pays for drugs that could make a difference in people’s health? As postage-meter maker Pitney Bowes Inc. (NYSE:PBI) found out, more people take their medicines, reports NPR.
Two-digit cut in Medicare pay. Physician pay will go down by 21 percent on Dec. 1 and another 4 percent on Jan. 1, according to a final payment rule issued by the Centers for Medicare and Medicaid Services, MedPage Today reports.
Liver problems? Don’t worry, we’ll grow you a new one eventually. That was the message from researchers at Wake Forest University’s Institute for Regenerative Medicine who have created part of a liver using human cells, according to the Singularity Hub blog.
Eli Lilly goes to China. Indianapolis-based Eli Lilly and Co. (NYSE:LLY) will open a research center in Shanghai by mid-2011 to search for new treatments for diabetes in China, according to the Indianapolis Star.
Social Network and autism. After seeing The Social Network, the movie that tells a story about how brilliant but socially inept Harvard computer science geek Mark Zuckerberg created Facebook, Psychology Today blogger Norman Holland had one conclusion: “It seemed to me perfectly clear when I saw the movie that Zuckerberg, again, as portrayed, was a classic case of Asperger’s [Syndrome].”
Pradaxa sold here. Boehringer Ingelheim Pharmaceuticals’ Pradaxa capsules (dabigatran etexilate) to prevent strokes and blood clots in patients with atrial fibrillation go on sale at U.S. pharmacies today. The wholesale price for a daily dose of two capsules? $6.75.
